Estrace combined with Estratab

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Breast Cancer Other Serious 1/21/1999 74 Female 2/6/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 7/21/1999 69 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 10/4/2002 Female 12/23/2005 United States
Primary
Secondary
Concomitant
Progesterone Receptor Assay Positive Other Serious 1/21/1999 74 Female 2/7/2006 United States
Primary
Secondary
Breast Cancer Other Serious 3/1/2004 Female 12/23/2005 United States
Primary
Secondary
Vitreous Haemorrhage Other Serious 2/21/2000 Female 2/14/2006 Consumer United States
Primary
Secondary
Breast Cancer In Situ Other Serious 8/6/1998 63 Female 4/11/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 1/2/2001 64 Female 4/11/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 3/1/2004 Female 4/17/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 10/4/2002 Female 2/8/2006 Consumer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 6/2/2001 64 Female 4/12/2006 United States
Primary
Secondary
Oestrogen Receptor Assay Positive Other Serious 8/6/1998 63 Female 4/13/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/1994 68 Female 106 lb 8/1/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 6/2/2001 64 Female 7/7/2006 Consumer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 6/2/2001 Female 156 lb 12/30/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 3/1/2004 Female 10/6/2006 United States
Primary
Secondary
Breast Cancer Other Serious 3/1/2004 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 6/1/2001 Female 165 lb 2/22/2007 United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 3/1/2001 Female 2/22/2007 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 3/1/2001 Female 2/22/2007 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 4/1/2002 61 Female 198 lb 3/28/2007 United States
Primary
Secondary
Concomitant
Mastectomy Other Serious 1/25/2002 Female 11/3/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 7/21/1999 63 Female 150 lb 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/21/1999 74 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 10/1/2000 59 Female 156 lb 2/7/2007 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 3/1/2004 Female 4/6/2007 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Visual Disturbance Other Serious 5/1/1993 56 Female 160 lb 8/4/2007 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 3/1/2001 Female 8/21/2007 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 1/21/1999 74 Female 10/8/2007 Consumer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 4/1/2002 61 Female 190 lb 11/3/2007 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 8/5/1998 64 Female 10/12/2007 United States
Primary
Secondary
Breast Cancer Other Serious 6/1/2001 65 Female 12/18/2007 United States
Primary
Secondary
Breast Cancer Other Serious 3/1/2001 Female 1/31/2008 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 10/1/2000 59 Female 157 lb 2/5/2007 Lawyer United States
Primary
Secondary
Vascular Dementia Other Serious Female 5/21/2008 Consumer United States
Primary
Secondary
Vascular Dementia Other Serious Female 5/21/2008 Consumer United States
Primary
Secondary
Vascular Dementia Other Serious Female 5/21/2008 Consumer United States
Primary
Secondary
Vascular Dementia Other Serious Female 5/21/2008 Consumer United States
Primary
Secondary
Vascular Dementia Other Serious Female 5/21/2008 Consumer United States
Primary
Secondary
Visual Disturbance Other Serious 1/1/1990 Female 160 lb 6/13/2008 United States
Primary
Secondary
Concomitant
Cholecystitis Chronic Other Serious 1/1/2001 57 10/9/2008 United States
Primary
Secondary
Breast Cancer Other Serious 10/4/1994 68 Female 10/9/2008 United States
Primary
Secondary
Breast Cancer Other Serious 3/1/2000 48 Female 10/9/2008 United States
Primary
Secondary
Breast Cancer Other Serious 3/1/2004 56 Female 10/9/2008 United States
Primary
Secondary
Breast Cancer Other Serious 1/31/2002 Female 10/9/2008 United States
Primary
Secondary
Breast Cancer Other Serious 2/1/1996 56 Female 10/9/2008 United States
Primary
Secondary
Breast Cancer Other Serious 9/30/2003 63 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 10/4/2002 56 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 1/21/1999 56 Female 12/19/2008 United States
Primary
Secondary
Cerebrovascular Accident Other Serious 1/1/2002 48 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 8/13/2002 Female 2/12/2009 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 6/1/2001 59 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/1994 68 Female 106 lb 3/19/2009 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 3/1/2004 Female 3/26/2009 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 6/2/2001 Female 4/10/2009 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 1/21/1999 Female 4/17/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious Female 4/20/2009 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 3/1/2001 Female 146 lb 4/21/2009 Lawyer United States
Primary
Secondary
Breast Cancer In Situ Other Serious 8/6/1998 Female 150 lb 5/8/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 3/15/2002 Female 5/11/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 10/4/2002 Female 5/15/2009 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 1/1/1994 68 Female 106 lb 5/15/2009 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 2/1/1996 Female 6/8/2009 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 1/1/1994 Female 106 lb 6/9/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 7/21/1999 Female 150 lb 6/16/2009 Consumer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 2/1/2000 Female 150 lb 6/19/2009 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 3/1/2001 Female 8/17/2009 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2002 Female 8/17/2009 Consumer United States
Primary
Secondary
Breast Cancer Other Serious Male 8/17/2009 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 7/21/1999 Female 150 lb 8/28/2009 Consumer United States
Primary
Secondary
Concomitant
Cerebrovascular Accident Other Serious Female 8/28/2009 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 2/1/1996 Female 9/16/2009 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 2/1/2000 Female 150 lb 9/18/2009 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 7/1/1999 Female 10/7/2009 Consumer United States
Primary
Secondary
Visual Impairment Other Serious 1/1/1990 Female 160 lb 3/3/2010 United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 3/18/1996 56 Female 5/4/2010 Lawyer United States
Primary
Secondary
Visual Impairment Other Serious 1/1/1990 47 Female 160 lb 5/19/2010 United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 7/13/1999 69 Female 4/5/2010 United States
Primary
Secondary
Breast Cancer Female Other Serious 3/4/2003 62 Female 4/5/2010 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 1/31/2002 Female 4/5/2010 United States
Primary
Secondary
Breast Cancer Other Serious 8/5/1998 64 Female 6/23/2010 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 1/1/2007 58 Female 4/5/2010 United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 8/13/2002 57 Female 4/5/2010 United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 1/31/2002 Female 6/24/2010 Lawyer United States
Primary
Secondary

Drug Data